FLC
GSK icon

Francis L. Coolidge’s GSK GSK Stock Holding History

Francis L. Coolidge’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$458K Buy
+7,340
New +$466K 0.56% 57

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Francis L. Coolidge's GSK Position: Q2 2013 in Review

Francis L. Coolidge opened a new position in GSK (GSK) in Q2 2013: 7,340 shares worth $458K. The stake represents 0.56% of the portfolio and ranks #57 among its holdings.

639 funds tracked by Wall St. Rank hold GSK as of Q2 2013.

  • Francis L. Coolidge held 7,340 shares of GSK worth $458K as of Q2 2013.
  • GSK was a new Francis L. Coolidge position in Q2 2013.
  • GSK made up 0.56% of Francis L. Coolidge's portfolio in Q2 2013, its #57 holding.
  • 639 funds tracked by Wall St. Rank held GSK as of Q2 2013.

Based on Francis L. Coolidge's 13F filing for Q2 2013, filed 7 Aug 2013.